Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 25.39T | 25.75T | 9.50T | 10.02T | 8.81T | 6.87T |
Gross Profit | 10.96T | 10.91T | 9.50T | 10.55T | 9.07T | 6.87T |
EBITDA | 5.10T | 5.39T | 4.40T | 5.48T | 4.48T | 2.54T |
Net Income | 2.88T | 3.09T | 2.51T | 3.19T | 2.54T | 1.31T |
Balance Sheet | ||||||
Total Assets | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
Cash, Cash Equivalents and Short-Term Investments | 69.50T | 71.08T | 68.45T | 67.30T | 46.69T | 40.02T |
Total Debt | 85.51T | 83.82T | 76.36T | 73.39T | 69.96T | 58.28T |
Total Liabilities | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
Stockholders Equity | 34.18T | 34.10T | 31.67T | 28.76T | 25.84T | 23.05T |
Cash Flow | ||||||
Free Cash Flow | -8.57T | -6.54T | -13.72T | 18.28T | -2.06T | 3.34T |
Operating Cash Flow | -8.25T | -6.13T | 1.62T | 18.62T | -1.80T | 3.61T |
Investing Cash Flow | 2.91T | -34.30B | -2.25T | -6.97T | -10.67T | -1.46T |
Financing Cash Flow | 9.84T | 1.25T | -2.86T | 1.92T | 9.08T | 2.37T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $13.20B | 14.11 | 16.25% | 12.56% | -8.82% | 4.87% | |
76 Outperform | $11.88B | 10.38 | 24.13% | 5.18% | 12.43% | 56.30% | |
73 Outperform | $15.05B | 11.58 | 22.07% | 6.92% | -13.16% | -8.10% | |
70 Outperform | $19.41B | 18.88 | 9.43% | 5.65% | -3.77% | -10.59% | |
68 Neutral | $18.06B | 11.97 | 10.24% | 3.74% | 9.75% | 1.30% | |
66 Neutral | $12.96B | 6.71 | 8.90% | 3.45% | -3.55% | 1.59% | |
64 Neutral | $21.98B | 7.30 | 8.58% | 2.51% | -3.83% | 4.06% |